Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

Published:2017-11 Issue:6 Volume:21 Page:627-637
ISSN:1413-8670
Container-title:The Brazilian Journal of Infectious Diseases
language:en
Short-container-title:The Brazilian Journal of Infectious Diseases

Author:

Pfaller Michael A.,Shortridge Dee,Sader Helio S.,Gales Ana,Castanheira Mariana,Flamm Robert K.

Funder

Merck & Co., Inc.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference21 articles.

1. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America;Boucher;Clin Infect Dis,2009

2. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance ProGram (Latin America, 2008–2010);Gales;Diagn Microbiol Infect Dis,2012

3. Susceptibility rates in Latin American nations: report from a regional resistance surveillance proGram (2011);Jones;Braz J Infect Dis,2013

4. Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study;Marra;J Clin Microbiol,2011

5. Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007–2009 study;Zhanel;Diagn Microbiol Infect Dis,2011

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Emergent Change in Epidemiologic and Microbiological Characteristics of Bloodstream Infections in Adults With Febrile Neutropenia Resulting From Chemotherapy for Acute Leukemia and Lymphoma at Reference Centers in Chile, Ecuador, and Peru;Open Forum Infectious Diseases;2024-02-01

2. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections;Clinical Infectious Diseases;2023-07-18

3. Evaluation of In Vitro Activity of Ceftolozane/Tazobactam and Ceftazidime/Avibactam Against Carbapenem-Resistant Pseudomonas aeruginosa Strains and Mechanisms of Carbapenem Resistance: Data from Tertiary Care Hospital;Jundishapur Journal of Microbiology;2023-06-04

4. In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa collected in the Study for Monitoring Antimicrobial Resistance Trends (SMART) between 2016 and 2019 in China;International Journal of Antimicrobial Agents;2023-04

5. Satisfactory In Vitro Activity of Ceftolozane–Tazobactam against Carbapenem-Resistant Pseudomonas aeruginosa But Not against Klebsiella pneumoniae Isolates;Medicina;2023-03-07